Mobile App

Google Play Apple Store
Independent Coverage of the International Liver Congress 2021*
Certified AMA/ANCC/ACPE Activity - Clinical Clips
NAFLD and resulting NASH are highly prevalent globally and in the United States, where they are a growing cause of cirrhosis, HCC, and increasingly an indicator for liver transplantation. The total burden of disease due to NASH will likely rise for the next 15 years.

These educational Clinical Clips will spotlight the latest and most relevant clinical data in the advances in the treatment and management of non‐alcoholic steatohepatitis (NASH) with a series of ‘what you need to know’ videos from data presented at the virtual International Liver Congress from June 23‐26.
Review one or all Clinical Clips of interest. Claim AMA, ANCC or ACPE credit/contact hour(s) after completion of each brief Post-Test/Evaluation.

 



 

Stephen Harrison, MD, FACP, FAASLD Stephen Harrison, MD, FACP, FAASLD
Consultant
Peak Consulting, LLC
 

*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the International Liver Congress 2021.
20

Supported by an independent educational grant from Theratechnologies


Launch Date: June 25, 2021

Release Date: June 23, 2021

Expiration Date: May 31, 2022

May 31, 2022
Mini Module
7078
ClinicalClips_WebBanner.NASH(1150).gif
Liver Disease